Although we only focused on FATP2 in the deep functional study in Andro-treated LO2 cells considering the extremely low expression of FATP5 (Ct value of more than 30), the potential role of FATP5 in the anti-hepatic-steatosis effect of Andro should not be excluded, as Andro treatment also robustly suppressed the expression of FATP5 in the liver tissue of HFD-fed mice (Fig. 4g). Here, SLC27A2 is linked to steatosis.